These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18162265)

  • 1. Protective immune response in mice vaccinated with a recombinant adenovirus containing capsid precursor polypeptide P1, nonstructural protein 2A and 3C protease genes (P12A3C) of encephalomyocarditis virus.
    Chen Z; Guo X; Ge X; Jia H; Yang H
    Vaccine; 2008 Jan; 26(4):573-80. PubMed ID: 18162265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Recombinant Adenovirus Expressing P12A and 3C Protein of the Type O Foot-and-Mouth Disease Virus Stimulates Systemic and Mucosal Immune Responses in Mice.
    Xie Y; Gao P; Li Z
    Biomed Res Int; 2016; 2016():7849203. PubMed ID: 27478836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of VP1-specific immune responses and protection against EMCV-K challenge by co-delivery of IL-12 DNA with VP1 DNA vaccine.
    Suh YS; Ha SJ; Lee CH; Sin JI; Sung YC
    Vaccine; 2001 Feb; 19(15-16):1891-8. PubMed ID: 11228358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase.
    Cedillo-Barrón L; Foster-Cuevas M; Belsham GJ; Lefèvre F; Parkhouse RME
    J Gen Virol; 2001 Jul; 82(Pt 7):1713-1724. PubMed ID: 11413383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of adenovirus-mediated small interfering RNAs against encephalomyocarditis virus challenge in mice.
    Bai J; Jiang K; Zhang L; Wang X; Wang X; Li Y; Jiang P
    J Virol Methods; 2012 Nov; 185(2):204-12. PubMed ID: 22790206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus.
    Yang NS; Wang JH; Lin KF; Wang CY; Kim SA; Yang YL; Jong MH; Kuo TY; Lai SS; Cheng RH; Chan MT; Liang SM
    J Gene Med; 2005 Jun; 7(6):708-17. PubMed ID: 15693054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18.
    Mingxiao M; Ningyi J; Juan LH; Min Z; Guoshun S; Guangze Z; Huijun L; Xiaowei H; Minglan J; Xu L; Haili M; Yue J; Gefen Y; Kuoshi J
    Antiviral Res; 2007 Oct; 76(1):59-67. PubMed ID: 17606304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte-macrophage colony stimulating factor gene.
    Sin JI; Sung JH; Suh YS; Lee AH; Chung JH; Sung YC
    Vaccine; 1997 Dec; 15(17-18):1827-33. PubMed ID: 9413089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses and expression of the virus-like particle antigen of the porcine encephalomyocarditis virus.
    Jeoung HY; Lee WH; Jeong W; Ko YJ; Choi CU; An DJ
    Res Vet Sci; 2010 Oct; 89(2):295-300. PubMed ID: 20378136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine.
    Wu Q; Moraes MP; Grubman MJ
    Virus Res; 2003 Jun; 93(2):211-9. PubMed ID: 12782369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant pseudorabies virus expressing P12A and 3C of FMDV can partially protect piglets against FMDV challenge.
    Zhang K; Huang J; Wang Q; He Y; Xu Z; Xiang M; Wu B; Chen H
    Res Vet Sci; 2011 Aug; 91(1):90-94. PubMed ID: 20947111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins.
    Chinsangaram J; Beard C; Mason PW; Zellner MK; Ward G; Grubman MJ
    J Virol; 1998 May; 72(5):4454-7. PubMed ID: 9557740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs.
    Yao Q; Qian P; Huang Q; Cao Y; Chen H
    J Virol Methods; 2008 Jan; 147(1):143-50. PubMed ID: 17963851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge.
    Wang G; Pan L; Zhang Y; Wang Y; Zhang Z; Lü J; Zhou P; Fang Y; Jiang S
    PLoS One; 2011; 6(11):e27605. PubMed ID: 22110686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
    Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
    Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of the capsid precursor and a nine-amino-acid site-directed mutant of the 3C protease of foot-and-mouth disease virus coexpressed by a recombinant goatpox virus.
    Ma W; Wei J; Wei Y; Guo H; Jin Y; Xue Y; Wang Y; Yi Z; Liu L; Huang J; Wang L
    Arch Virol; 2014 Jul; 159(7):1715-22. PubMed ID: 24473707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
    Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
    J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
    Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
    Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of foot-and-mouth disease virus capsid precursor protein and 3C protease expression on bovine herpesvirus 1 replication.
    Klopfleisch C; Minh LQ; Giesow K; Curry S; Keil GM
    Arch Virol; 2010 May; 155(5):723-31. PubMed ID: 20333533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.